We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 21, 2023

Adjuvant Chemotherapy for ER−/HER2− T1abN0 Breast Cancer

Breast Cancer Research and Treatment


Additional Info

Breast Cancer Research and Treatment
Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study
Breast Cancer Res Treat 2022 Dec 28;[EPub Ahead of Print], CMS Hassing, MK Mejdahl, AV Lænkholm, N Kroman, AS Knoop, THF Tvedskov

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading